GAST and chronic atrophic gastritis: This is reflected in the evidence that patients with H. pylori-induced atrophic gastritis and those receiving PPIs exhibited marked differences in 16S rRNA microbiota profiles, co-occurrence networks and predicted pathways, despite similar gastrin levels.